TLDR
Drug development is an incredibly difficult, protracted, and expensive process. AstraZeneca are looking at the way they recruit for clinical trials as a possible area for optimisation. Paul Agapow, Health Informatics Director at Astra Zeneca, spoke about his team’s work in building a social graph to reduce time and financial resources when recruiting for clinical trial trials. The social graph — knowledge graph — to improve clinical trials' processes and reduce costs by providing better clarity and access to heterogeneous datasets.via the TL;DR App
no story
Written by danielcrowe | Chicago > NYC > London @ Vaticle
